Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
7.31
-0.59 (-7.47%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Champions Oncology Employees
Champions Oncology had 210 employees as of April 30, 2024. The number of employees decreased by 20 or -8.70% compared to the previous year.
Employees
210
Change (1Y)
-20
Growth (1Y)
-8.70%
Revenue / Employee
$279,005
Profits / Employee
$30,605
Market Cap
100.20M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
CSBR News
- 21 hours ago - Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House - Accesswire
- 4 days ago - Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine - Accesswire
- 6 weeks ago - Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million - Accesswire
- 7 weeks ago - Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 - Accesswire
- 2 months ago - Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting - Accesswire
- 3 months ago - Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership - Accesswire
- 4 months ago - Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies - Seeking Alpha